Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer

Cancer Diagnosis and Prognosis · Published 2026-03-01 · DOI 10.21873/cdp.10536

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.21873/cdp.10536

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles